Texans are among the nation's lowest 988 users
Texas ranks 46th nationwide for 988 calls per capita, a new analysis finds.
Why it matters: Use of the 988 national suicide prevention and mental health hotline remains uneven nationwide.
The service was launched nearly three years ago to help address America's mental health crisis — but gaps persist.
Driving the news: The service received 18.5 contacts per 1,000 Texans in 2024, per new research published in JAMA Network Open.
Alaska (45.3 contacts per 1,000 people), Vermont (40.2) and New York (38.8) had the highest 988 contact rates among states in 2024.
Delaware (12.5), Alabama (14.4) and Florida (15.6) had the lowest.
The big picture: The 988 service fielded more than 16.3 million calls, texts and chats between July 2022 and the end of 2024.
The national contact rate was 48.9 per 1,000 people during that period, and 23.7 in 2024 alone.
How it works: "Contacts" include all calls, texts and chats sent to 988, including those forwarded along to more specific services, like the Veterans Crisis Line and the LGBTQ+ Line.
Geography for calls and chats was assigned based on users' phone numbers, while texts were assigned by ZIP codes shared during pre-chat surveys.
What they're saying: Several factors may be contributing to the state and regional differences in 988 use, says study author Jonathan Purtle, associate professor and director of policy research at New York University's School of Global Public Health.
That includes differences in how 988 is being advertised by states and cities, as well as political attitudes.
Many Americans remained unfamiliar with 988 as of last summer, per Ipsos polling.
And surveys have found that Democrats are more likely than Republicans to use 988, Purtle says: "We see this shake out in the map — in the South and more right-leaning places, we see lower volume."
Caveat: Less populous states have more variability due to their relatively smaller sample sizes, Purtle notes.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBS News
7 hours ago
- CBS News
NYC-based organizations offer support for LGBTQ+ youth as suicide hotline option is terminated
New York City-based organizations are highlighting the need for resources for LGBTQ+ residents after the Trump administration announced it will end LGBTQ+ youth suicide prevention services in a few weeks. The Trevor Project has been helping LGBTQ+ youth for decades and started providing specialized support for LGBTQ+ callers to the 988 National Suicide Prevention Hotline in 2022, but it has received a stop work order effective July 17. The federal Substance Abuse and Mental Health Services Administration said LGBTQ+ callers can still rely on hotline's general services, but advocates say this will greatly impact LGBTQ+ youth. "There's someone here to help you" "LGBTQ+ youth in our country are experiencing a mental health crisis," said Mark Henson, the Trevor Project's interim vice president of advocacy and government affairs. "That's the reason why these services were set up, so that tailored care can be available to help keep them alive." According to the nonprofit organization, 39% of LGBTQ+ young New Yorkers seriously considered suicide in the past year, and 12% attempted it. A recent study also revealed LGBTQ+ youth are four times more likely to attempt suicide compared to their peers. "If this program goes away, the question is will they feel comfortable reaching out?" Henson said. The Trevor Project says it will continue to provide crisis services through its own hotline, but it will be a lot harder. Henson has a message for LGBTQ+ youth struggling with mental health. "You deserve the right for support, and there's someone here to help you," he said. For more information on the services offered by the Trevor Project, visit Unique services available for LGBTQ+ youth in NYC The Queens Community House in Forest Hills has unique services specifically for LGBTQ+ youth, including a drop-in center. "We see that those individuals often feel more welcome and safe in dedicated programming and thrive there," Executive Director Ben Thomases said. "They know they're gonna be understood. They know that people are going to see them for who they are." Thomases said the organization is also doing work in schools throughout the borough to make that environment more welcoming, as well. For more information, visit Jewish Queer Youth (JQY) offers support to young Jewish New Yorkers struggling to find acceptance in their communities. "Cutting services for LGBTQ youth through the 988 Suicide and Crisis Hotline will really have devastating and deadly consequences," Executive Director Rachael Fried said. "The fact that it exists, it sends a message that queer youth actually matter." There's still a few weeks before the youth service is eliminated. Advocates are petitioning and pushing for lawmakers to step in. In May, more than 100 House members signed a letter urging the health department to preserve the LGBTQ+ option, and seven senators signed a similar letter. If you or someone you know needs help, you can call or text 988 to speak with a trained, caring counselor 24 hours a day, seven days a week. You can also chat online with a counselor at
The Hill
13 hours ago
- The Hill
3 in 4 want legally required, publicly disclosed presidential health tests: Survey
Three in four Americans want health test requirements for presidents that would be released to the public, a new survey released on Friday found. Seventy-four percent of respondents agreed there should be legal requirements for the sitting president to share health records, in an Axios/Ipsos poll, and 72 percent of respondents thought most elected officials aren't honest about their own health. Additionally, 81 percent of respondents said there should be age limits in place for federal officials, including presidents, Supreme Court justices and members of Congress. Only 40 percent of respondents said former presidents should legally have to share health records. The issue of health and cognitive abilities of sitting presidents has been in the spotlight since former President Biden's disastrous debate in June and eventual decision not to run for reelection. He was 82 when he left office and recently announced he was diagnosed with prostate cancer. Earlier this week, Senate Judiciary Committee Republicans accused former Biden Cabinet officials, Democratic members of Congress and the media of participating in a massive 'cover-up' to hide what they claim was the former president's obvious and alarming cognitive decline during his final two years in office. President Trump, who just turned 79 last week, is the oldest president to be inaugurated. He underwent an annual physical exam in April and his physician wrote in a memo that he was in 'excellent health.' The memo confirmed that Trump took the Montreal Cognitive Assessment, a test commonly used to detect memory issues or cognitive impairment, and scored a 30 out of 30. Since he first left office in 2020, Trump had released limited information about his physical health. His campaign released a letter in November 2023 from his personal physician, with little specifics. Nikki Haley, Trump's former U.N. ambassador who challenged him in the 2024 GOP primary, called for cognitive tests for politicians over 75. 'To most Americans, this is common sense. But many political and media elites scoff at these ideas,' she wrote in May 2023. The survey was conducted June 13 to 16 and included 1,104 U.S. adults. It has a margin of error of +/-3.3 percentage points.
Medscape
16 hours ago
- Medscape
Oseltamivir Decreases Hospital Mortality Risk of Influenza
Treating patients with severe influenza with oseltamivir in the first 2 days after hospital admission was associated with a lower in-hospital mortality risk, earlier discharge, and lower readmission rate compared with supportive care, new data indicated. The additional evidence supports current guideline recommendations to treat all people hospitalized with influenza with an antiviral agent, regardless of how long they have been ill. The study, led by Anthony D. Bai, MD, assistant professor of infectious diseases at Queen's University in Kingston, Ontario, was published on June 10 in JAMA Network Open. Reduced Mortality Risk Each year, influenza causes 12,200 hospitalizations and 3500 deaths in Canada. It causes between 140,000 and 810,000 hospitalizations and 12,000 to 61,000 deaths in the United States. And despite guidelines in both countries that recommend treatment for all entering the hospital with influenza, clinical practice varies widely, Bai told Medscape Medical News . The researchers' study found that in Ontario, 30% of clinicians were not treating this population with oseltamivir. Researchers examined data from the General Medicine Inpatient Initiative database, which includes internal medicine and intensive care unit (ICU) patients admitted to participating hospitals in Ontario. Data included demographics, diagnoses, interventions, discharge, readmission, medication orders, and bloodwork results. The cohort study included 11,073 patients (average age, 72.6 years). Researchers found an adjusted risk reduction of 1.8% for in-hospital mortality when oseltamivir was given, compared with supportive care median length of stay was 4.4 days and 4.9 days in the oseltamivir and supportive care groups, respectively. After discharge, 645 patients (8.5%) in the oseltamivir group and 336 patients (9.8%) in the supportive care group were readmitted, with an adjusted risk difference of -1.5%. 'Some clinicians believe there won't be much benefit to treatment with oseltamivir,' said Bai, likely because of the dearth of evidence supporting the guidelines. 'There's been a lot of controversy about the benefit of oseltamivir in the outpatient population, where a recent meta-analysis showed it didn't really prevent hospitalizations. But there is a signal that it decreased in-hospital mortality. If a similar benefit is proven in a future randomized, controlled trial, it would add a lot of convincing evidence that there's a significant benefit to oseltamivir treatment.' The expanded version of the large RECOVERY randomized, controlled trial in the United Kingdom looks at that question, he noted. But until results are available, 'we should go by the current guideline recommendations.' Remaining Questions Wendy Sligl, MD, professor of critical care medicine and infectious diseases at the University of Alberta in Edmonton, told Medscape Medical News that the 1.8% in-hospital mortality reduction may seem small. 'Keep in mind, this is in all hospitalized patients, which includes a spectrum of disease severity from those not needing supplemental oxygen to those on a ventilator.' She pointed out that less than 10% of the patients in this study were admitted to the ICU. The number needed to treat is an important consideration with these results, she pointed out. 'Given this mortality reduction, you would need to treat approximately 55 patients to prevent one death. When the outcome is as devastating as death, and the drug is relatively safe and inexpensive, treatment seems reasonable, given even a small reduction in mortality.' Sligl also noted the need for high-quality evidence from randomized, controlled trials, including RECOVERY, in hospitalized patients with influenza. 'In addition, the most severe patients, those in the ICU with respiratory failure requiring high-flow oxygen or mechanical ventilation, should be specifically studied.' Beyond whether antiviral therapy is beneficial, she said, other questions remain, such as which antiviral is best and at what dose and duration. Other questions include whether an antiviral therapy should be used alone or in combination with another antiviral therapy and at what time in which patients. 'The best quality data we have for the treatment of influenza are in healthy outpatients, where treatment has been shown to reduce symptom severity and duration. Data for antiviral use in hospitalized patients with influenza are largely observational, suggesting a small mortality benefit with treatment,' Sligl explained. In the current study, she noted, 'target trial emulation with propensity scoring helped to minimize bias, which is a methodologic strength.' No funding source for this study was reported. Bai and Sligl reported having no relevant financial relationships.
